AstraZeneca Current Ratio 2006-2018 | AZN

Current and historical current ratio for AstraZeneca (AZN) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. AstraZeneca current ratio for the three months ending December 31, 2018 was 0.96.
AstraZeneca Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $15.59B $16.29B 0.96
2018-09-30 $13.11B $15.25B 0.86
2018-06-30 $12.45B $17.20B 0.72
2018-03-31 $13.18B $18.16B 0.73
2017-12-31 $13.15B $16.38B 0.80
2017-09-30 $13.63B $14.46B 0.94
2017-06-30 $14.30B $15.66B 0.91
2017-03-31 $11.64B $15.43B 0.75
2016-12-31 $13.26B $15.26B 0.87
2016-09-30 $12.87B $15.38B 0.84
2016-06-30 $13.32B $14.34B 0.93
2016-03-31 $12.77B $15.93B 0.80
2015-12-31 $16.01B $14.87B 1.08
2015-09-30 $13.20B $16.04B 0.82
2015-06-30 $13.81B $16.15B 0.86
2015-03-31 $12.69B $15.76B 0.81
2014-12-31 $16.70B $17.33B 0.96
2014-09-30 $15.07B $15.82B 0.95
2014-06-30 $16.20B $16.32B 0.99
2014-03-31 $16.54B $17.51B 0.95
2013-12-31 $20.34B $16.05B 1.27
2013-09-30 $18.79B $14.68B 1.28
2013-06-30 $19.39B $15.20B 1.28
2013-03-31 $18.34B $13.86B 1.32
2012-12-31 $19.05B $13.90B 1.37
2012-09-30 $18.03B $14.13B 1.28
2012-06-30 $19.78B $14.80B 1.34
2012-03-31 $21.56B $15.80B 1.37
2011-12-31 $23.51B $15.75B 1.49
2011-09-30 $22.47B $14.66B 1.53
2011-06-30 $22.69B $13.84B 1.64
2011-03-31 $23.47B $16.02B 1.47
2010-12-31 $25.13B $16.79B 1.50
2010-09-30 $24.57B $16.85B 1.46
2010-06-30 $23.38B $16.30B 1.43
2010-03-31 $22.35B $16.99B 1.32
2009-12-31 $23.76B $17.64B 1.35
2009-09-30 $20.54B $15.12B 1.36
2009-06-30 $19.13B $15.14B 1.26
2009-03-31 $15.85B $14.05B 1.13
2008-12-31 $16.15B $13.32B 1.21
2008-09-30 $15.60B $14.38B 1.09
2008-06-30 $16.59B $15.99B 1.04
2008-03-31 $14.69B $15.68B 0.94
2007-12-31 $17.08B $15.19B 1.13
2007-09-30 $0.00B $0.00B 0.00
2007-06-30 $16.08B $24.93B 0.65
2007-03-31 $16.29B $10.35B 1.57
2006-12-31 $16.94B $9.45B 1.79
2006-09-30 $14.43B $8.09B 1.78
2006-06-30 $15.05B $8.41B 1.79
2006-03-31 $13.51B $7.14B 1.89
2005-12-31 $13.77B $6.84B 2.01
2005-09-30 $13.10B $6.74B 1.94
2005-06-30 $13.44B $6.80B 1.98
2005-03-31 $12.70B $6.84B 1.86
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $99.543B $22.090B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $370.294B 16.79
Pfizer (PFE) United States $243.591B 13.64
Merck (MRK) United States $209.116B 17.87
Novartis AG (NVS) Switzerland $183.275B 15.59
Eli Lilly (LLY) United States $124.257B 21.58
Novo Nordisk (NVO) Denmark $120.735B 19.53
AbbVie (ABBV) United States $118.316B 10.14
Sanofi (SNY) France $104.713B 12.93
GlaxoSmithKline (GSK) United Kingdom $99.894B 13.12
Bristol-Myers Squibb (BMY) United States $75.195B 11.56